Structural interventions

Residual challenges in TAVI: moving forward

EuroIntervention 2019;15:857-866. DOI: 10.4244/EIJ-D-19-00788

Marco Barbanti
Marco Barbanti1, MD; John G. Webb2, MD; Danny Dvir3, MD; Bernard D. Prendergast4, MD
1. A.O.U. Policlinico-Vittorio Emanuele, University of Catania, Catania, Italy; 2. St. Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada; 3. University of Washington, Seattle, WA, USA; 4. Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom

Transcatheter aortic valve implantation (TAVI) has, in less than 20 years, become the dominant interventional treatment for aortic stenosis in developed countries. Its development has been characterised by the growth of procedural expertise and device improvement. Every aspect of this therapy has been investigated, increasing clinical evidence and leading to continued optimisation. The purpose of this review article is to provide an overview of the rapidly changing field of TAVI therapy, briefly describing key past achievements and discussing residual challenges.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic stenosisbicuspid aortic valvecoronary accessprosthesistavrvalve-in-valve
Read next article
Transcatheter mitral repair and replacement: which procedure for which patient?

Latest news